Videoconferenced Yoga Interventions for Cancer Patients and their Caregivers during the COVID-19 Pandemic: A Report from a Clinician's Perspective.
Stella Snyder, Rosangela F Silva, Meagan S Whisenant...
https://pubmed.ncbi.nlm.nih.gov/34036820Actively Recruiting
Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID03948100
Dyadic Behavioral Interventions to Manage Physical Performance, Symptoms and Quality of Life for Patients Undergoing Radiotherapy and Their Family Caregivers
Led by M.D. Anderson Cancer Center · Updated on 2026-04-15
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how a dyadic yoga program affects physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer who are undergoing radiotherapy, along with their caregivers. This study aims to see if yoga can improve physical function, reduce fatigue, ease sleep difficulties, lower depressive symptoms, and enhance overall quality of life compared to an education program. The study also explores changes in symptom burden, inflammatory markers, cortisol rhythms, and dyadic symptom management skills. Participants are randomly assigned to one of two groups: one group takes part in dyadic yoga sessions involving physical exercises and relaxation techniques lasting 60 minutes each, up to 15 sessions; the other group receives dyadic education focused on managing symptoms for patients and caregivers, also lasting 60 minutes each for up to 15 sessions. After completing the intervention, participants are followed up every two weeks for three months, then monthly for up to six months. During the study, patient physical performance is measured with a 6-minute walk test at three months post-study. Quality of life assessments for both patients and caregivers continue for up to six months after the intervention. Researchers also collect data on symptom burden, inflammatory and cortisol markers, and participants’ experiences through questionnaires and ancillary studies. Safety monitoring and ongoing assessments help track the intervention's effects over the follow-up period.
CONDITIONS
Brief Title
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Diagnosed with stage I-IV non-small cell lung cancer or esophageal cancer
- Scheduled to receive at least 3 weeks of thoracic radiotherapy
- Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less
- Able to read, write, and speak English
- Able to provide informed consent
- Having a family caregiver who assists during cancer treatment; caregiver must be at least 18 years old, able to read, write, speak English, and provide consent
You will not qualify if you...
- Regularly participated in mind-body practices in the year prior to diagnosis
- Metastatic disease involving the central nervous system
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 15 sessions
Participants undergo either dyadic yoga intervention sessions involving physical exercises and relaxation techniques or dyadic education program sessions focusing on symptom management strategies. Each session lasts 60 minutes for up to 15 sessions.
Up to 15 sessions, each lasting 60 minutes
Follow-up
Duration - Up to 6 months post-treatment
Participants and their caregivers are followed up every 2 weeks for 3 months and then every month for up to 6 months after completing the treatment sessions.
Biweekly visits for 3 months, then monthly visits for up to 6 months
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Loading map...
Research Team
K
Kathrin Milbury
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here